Article
Validation of molecular classification on diagnostic biopsy in endometrial carcinoma: the first step for a tailored approach.
Journal of gynecologic oncology - 1 Jul 2026
Spagnol Giulia, Marchetti Matteo, Vezzaro Tommaso, Panizzolo Eleonora, Bigardi Sofia, De Tommasi Orazio, Guerriero Angela, Alessandrini Lara, Noventa Marco, Tozzi Roberto, Saccardi Carlo
Abstract excerpt
OBJECTIVE: To validate the concordance of histologic subtype, tumor grade, molecular classification, and risk group between pre-operative endometrial biopsy and final hysterectomy specimens in patients with endometrial cancer (EC). METHODS: The PReOperative MOlecular Biopsy (ProMobi) study is a prospective, monocentric, observational study conducted from September 2023 to March 2024. All patients with suspicious...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
